By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS


Industry
Pharmaceutical






Company News
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014 7:36:05 AM
RedHill Biopharma Ltd. (RDHL) Announces First Patients Enrolled In The Phase 3 Study Of RHB-102 (BEKINDA(TM)) For Gastroenteritis And Gastritis 12/17/2014 7:25:03 AM
RedHill Biopharma Ltd. (RDHL) Submits BEKINDA™ (RHB-102) European Marketing Authorization Application For Oncology Support 12/9/2014 10:39:03 AM
RedHill Biopharma Ltd. (RDHL)To Sponsor And Exhibit Its Ongoing Phase 3 Crohn's Program At The Israeli IBD Society Meeting 12/2/2014 11:53:40 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines 12/1/2014 10:30:25 AM
RedHill Biopharma Ltd. (RDHL) Reports Results For The Third Quarter Of 2014 11/10/2014 7:51:48 AM
FDA Grants QIDP Fast-Track Designation To RedHill Biopharma Ltd. (RDHL)'s Phase 3 H. Pylori Drug RHB-105 11/10/2014 7:32:47 AM
RedHill Biopharma Ltd. (RDHL) To Host Third Quarter 2014 Financial Results Conference Call On November 10, 2014 10/28/2014 7:02:57 AM
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference 10/22/2014 7:30:24 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
123456789
//-->